Protagonist Therapeutics
Australia - Brisbane
BiotechnologyFocus: Oral peptides
Protagonist Therapeutics is a life sciences company focused on Oral peptides.
HematologyImmunologyGastroenterology
Open Jobs
0
Pipeline & Clinical Trials
PTG-100
Celiac DiseaseClinical Trials (1)
NCT04524221PTG-100 for Patients With Celiac Disease
Phase 1PN-232
Healthy SubjectsClinical Trials (1)
NCT04819620Pharmacokinetics of PN-232 in Healthy Volunteers
Phase 1PN-881 Oral Solution
Healthy VolunteerClinical Trials (1)
NCT07153146Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of PN-881 in Healthy Subjects.
Phase 1PN-235
Healthy VolunteersClinical Trials (1)
NCT04621630Pharmacokinetics of PN-235 in Healthy Volunteers
Phase 1PTG-300
Healthy VolunteersClinical Trials (1)
NCT04516382Pharmacokinetics and Pharmacodynamics of Different PTG-300 Regimens in Healthy Volunteers
Phase 1PTG-300
Hereditary HemochromatosisClinical Trials (1)
NCT04202965PTG-300 in Subjects With Hereditary Hemochromatosis
Phase 2PTG-300
β-thalassemiaClinical Trials (1)
NCT03802201Study of PTG-300 in Non-Transfusion Dependent and Transfusion-Dependent Beta-Thalassemia Subjects With Chronic Anemia
Phase 2PTG-300
Polycythemia VeraClinical Trials (1)
NCT04767802PTG-300 in Patients With Polycythemia Vera and Elevated Hematocrit
Phase 2PTG-300
Polycythemia VeraClinical Trials (1)
NCT04057040Hepcidin Mimetic in Patients With Polycythemia Vera (REVIVE)
Phase 2Phase 2
Clinical Trials (1)
NCT04504383PN-943 in Adults With Moderate to Severe Active Ulcerative Colitis (UC)
Phase 2PTG-100
Ulcerative ColitisClinical Trials (1)
NCT02895100Safety and Efficacy Study of PTG-100 in the Treatment of Moderate to Severe Ulcerative Colitis
Phase 2PTG-300
β-thalassemiaClinical Trials (1)
NCT04054921Safety Study for Beta Thalassemia Subjects on PTG-300
Phase 2Open-label rusfertide
Polycythemia VeraClinical Trials (1)
NCT06033586Study to Evaluate the Long-term Safety of Rusfertide (PTG-300) in Subjects With Polycythemia Vera
Phase 3Placebo
Polycythemia VeraClinical Trials (1)
NCT05210790A Phase 3 Study of Rusfertide in Patients With Polycythemia Vera
Phase 3Open Jobs (0)
No open positions listed yet. Check their careers page directly.
Interview Prep Quick Facts
Portfolio: 14 clinical trials